Cargando…
3,6′- and 1,6′-Dithiopomalidomide Mitigate Ischemic Stroke in Rats and Blunt Inflammation
(1) Background: An important concomitant of stroke is neuroinflammation. Pomalidomide, a clinically available immunomodulatory imide drug (IMiD) used in cancer therapy, lowers TNF-α generation and thus has potent anti-inflammatory actions. Well-tolerated analogs may provide a stroke treatment and al...
Autores principales: | Tsai, Yan-Rou, Kim, Dong Seok, Hsueh, Shih-Chang, Chen, Kai-Yun, Wu, John Chung-Che, Wang, Jia-Yi, Tsou, Yi-Syue, Hwang, Inho, Kim, Yukyung, Gil, Dayeon, Jo, Eui Jung, Han, Baek-Soo, Tweedie, David, Lecca, Daniela, Scerba, Michael T., Selman, Warren R., Hoffer, Barry J., Greig, Nigel H., Chiang, Yung-Hsiao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9146426/ https://www.ncbi.nlm.nih.gov/pubmed/35631536 http://dx.doi.org/10.3390/pharmaceutics14050950 |
Ejemplares similares
-
Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury
por: Hsueh, Shih Chang, et al.
Publicado: (2022) -
3,6’-dithiopomalidomide reduces neural loss, inflammation, behavioral deficits in brain injury and microglial activation
por: Lin, Chih-Tung, et al.
Publicado: (2020) -
3,6′-Dithiopomalidomide Ameliorates Hippocampal Neurodegeneration, Microgliosis and Astrogliosis and Improves Cognitive Behaviors in Rats with a Moderate Traumatic Brain Injury
por: Huang, Pen-Sen, et al.
Publicado: (2021) -
Post-Injury Neuroprotective Effects of the Thalidomide Analog 3,6′-Dithiothalidomide on Traumatic Brain Injury
por: Batsaikhan, Buyandelger, et al.
Publicado: (2019) -
Role of chronic neuroinflammation in neuroplasticity and cognitive function: A hypothesis
por: Lecca, Daniela, et al.
Publicado: (2022)